Faricimab Efficacy, Safety Hold Up in Real-World Study

by Medscape • 2023/10/12 • 0 Comments

A real-world study of faricimab in neovascular age-related macular degeneration showed visual and anatomical improvement in line with phase 3 trials in treatment-naive and previously treated eyes.
Medscape Medical News

Full Story →

← Digital media may enhance patient understanding of glaucoma, glaucoma management

VTI annonce des données provisoires positives à un an de l'essai clinique PROTECT lors de la réunion annuelle de l'American Academy of Optometry →

Post navigation